(Institución)
 
 

Docu-menta > Investigación Básica > Artículos de Investigación Básica >

Por favor, use este identificador para citar o enlazar este ítem: http://documenta.ciemat.es/handle/123456789/2353

Título : Efficient and Fast Generation of Relevant Disease Mouse Models by In Vitro and In Vivo Gene Editing of Zygotes
Autor : Sanchez-Baltasar, Raquel
Garcia-Torralba, Aida
Nieto-Romero, Virginia
Page, Angustias
Molinos-Vicente, Andrea
López-Manzaneda, Sergio
Ojeda-Pérez, Isabel
Ramírez, Ángel
Navarro, Manuel
Segovia, José Carlos
García-Bravo, María
Palabras clave : gene editing
zygotes
primary hyperoxaluria
pyruvate kinase deficency
Rasa1
Agxt1
Pklr
mouse models
Fecha de publicación : jun-2022
Editorial : CRISPR Journal
Citación : Sanchez-Baltasar R, Garcia-Torralba A, Nieto-Romero V, Page A, Molinos-Vicente A, López-Manzaneda S, Ojeda-Pérez I, Ramirez A, Navarro M, Segovia JC, García-Bravo M. Efficient and Fast Generation of Relevant Disease Mouse Models by In Vitro and In Vivo Gene Editing of Zygotes. CRISPR J. 2022 Jun;5(3):422-434. doi: 10.1089/crispr.2022.0013. PMID: 35686982; PMCID: PMC9233508.
Resumen : Knockout mice for human disease-causing genes provide valuable models in which new therapeutic approaches can be tested. Electroporation of genome editing tools into zygotes, in vitro or within oviducts, allows for the generation of targeted mutations in a shorter time. We have generated mouse models deficient in genes involved in metabolic rare diseases (Primary Hyperoxaluria Type 1 Pyruvate Kinase Deficiency) or in a tumor suppressor gene (Rasa1). Pairs of guide RNAs were designed to generate controlled deletions that led to the absence of protein. In vitro or in vivo ribonucleoprotein (RNP) electroporation rendered more than 90% and 30% edited newborn animals, respectively. Mice lines with edited alleles were established and disease hallmarks have been verified in the three models that showed a high consistency of results and validating RNP electroporation into zygotes as an efficient technique for disease modeling without the need to outsource to external facilities.
URI : http://documenta.ciemat.es/handle/123456789/2353
Aparece en las colecciones: Artículos de Investigación Básica

Ficheros en este ítem:

Fichero Descripción Tamaño Formato
24. Sanchez-Baltasar- CRISPR J 2022.pdf1.12 MBAdobe PDFVisualizar/Abrir
View Statistics

Los ítems de Docu-menta están protegidos por una Licencia Creative Commons, con derechos reservados.

 

Información y consultas: documenta@ciemat.es | Documento legal